Challenges faced by primary care physicians when prescribing for patients with chronic diseases in a teaching hospital in Malaysia: a qualitative study

BMJ Open
Renukha SellappansChirk Jenn Ng

Abstract

The aim of this study was to identify the challenges faced by primary care physicians (PCPs) when prescribing medications for patients with chronic diseases in a teaching hospital in Malaysia. 3 focus group discussions were conducted between July and August 2012 in a teaching primary care clinic in Malaysia. A topic guide was used to facilitate the discussions which were audio-recorded, transcribed verbatim and analysed using a thematic approach. PCPs affiliated to the primary care clinic were purposively sampled to include a range of clinical experience. Sample size was determined by thematic saturation of the data. 14 family medicine trainees and 5 service medical officers participated in this study. PCPs faced difficulties in prescribing for patients with chronic diseases due to a lack of communication among different healthcare providers. Medication changes made by hospital specialists, for example, were often not communicated to the PCPs leading to drug duplications and interactions. The use of paper-based medical records and electronic prescribing created a dual record system for patients' medications and became a problem when the 2 records did not tally. Patients sometimes visited different doctors and pharmacies for the...Continue Reading

References

Aug 1, 1997·Journal of the American Geriatrics Society·J T HanlonI K Lewis
Jan 22, 2000·BMJ : British Medical Journal·C PopeN Mays
Oct 27, 2001·Journal of Clinical Pharmacy and Therapeutics·E VermeireJ Denekens
Feb 1, 2003·Annals of Internal Medicine·Arlyss Anderson Rothman, Edward H Wagner
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Jerry H GurwitzDavid W Bates
Apr 18, 2003·The New England Journal of Medicine·Tejal K GandhiDavid W Bates
Jul 18, 2003·The New England Journal of Medicine·Jesús Hernández, M Luisa Vargas
Dec 23, 2003·Journal of the American Geriatrics Society·Mark E WilliamsGary Koch
Jan 15, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yen-Fu ChenIvan H Stockley
Jun 2, 2005·Annals of Family Medicine·Truls ØstbyeJ Lloyd Michener
Aug 11, 2005·JAMA : the Journal of the American Medical Association·Cynthia M BoydAlbert W Wu
Oct 20, 2005·Pharmacotherapy·Barbara J ZarowitzEdward L Peterson
Sep 27, 2006·Archives of Internal Medicine·Derjung M TarnNeil S Wenger
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Jana M BajcarThomas R Einarson
Dec 15, 2006·British Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Jan 11, 2007·JAMA : the Journal of the American Medical Association·Jeppe N RasmussenDavid A Alter
Dec 6, 2007·Journal of General Internal Medicine·Christine VogeliDavid Blumenthal
Jan 15, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nancy T NkansahKenneth M Shermock
Apr 5, 2008·Clinical Pharmacology and Therapeutics·L DolovichC Sellors
Apr 11, 2008·The Journal of Clinical Hypertension·Barry L CarterArthur J Hartz
Jun 21, 2008·The New England Journal of Medicine·Catherine M DesRochesDavid Blumenthal
Jun 27, 2008·Journal of the American Medical Informatics Association : JAMIA·Elske AmmenwerthUwe Siebert
Aug 6, 2008·Quality & Safety in Health Care·G M KuoJ M Hickner
Jun 30, 2009·Alzheimer Disease and Associated Disorders·Denys T LauSandra Weintraub
May 5, 2010·The American Journal of Geriatric Pharmacotherapy·Manabu AkazawaKiichiro Tsutani
Jun 1, 2010·Quality & Safety in Health Care·Henry KoCaron Hill
Jul 16, 2010·Journal of Evaluation in Clinical Practice·Ravishankar RamaswamyBarbara Roehl
Dec 8, 2010·Nursing Standard·J Hill
Dec 15, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Desireé L Kunac, Michael V Tatley
Oct 25, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sarah P SlightAnthony J Avery
Jun 24, 2014·The International Journal of Pharmacy Practice·Janice O OlaniyanPaul Robinson

❮ Previous
Next ❯

Software Mentioned

Nvivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.